152 related articles for article (PubMed ID: 16316300)
1. Pharmacogenetics of colorectal cancer.
Marsh S
Expert Opin Pharmacother; 2005 Dec; 6(15):2607-16. PubMed ID: 16316300
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in colorectal cancer: a systematic review.
Funke S; Brenner H; Chang-Claude J
Pharmacogenomics; 2008 Aug; 9(8):1079-99. PubMed ID: 18681783
[TBL] [Abstract][Full Text] [Related]
3. [Role of pharmacogenetics in chemotherapy of colorectal cancers].
Ceppa F; Fontan E; Cremades S; Bihannic R; Bousquet A; Beauvillain L; Burnat P
Rev Med Interne; 2007 Sep; 28(9):594-602. PubMed ID: 17624636
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Stoehlmacher J; Goekkurt E; Lenz HJ
Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Seifi S; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2018; 24(23):2710-2718. PubMed ID: 30051785
[TBL] [Abstract][Full Text] [Related]
7. Individualizing chemotherapeutic treatment of colorectal cancer.
Crews KR
Am J Health Syst Pharm; 2006 May; 63(9 Suppl 2):S12-7. PubMed ID: 16641252
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
Cortejoso L; López-Fernández LA
Pharmacogenomics; 2012 Jul; 13(10):1173-91. PubMed ID: 22909207
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer: pharmacogenetics support for the correct drug prescription.
Olivera G; Sendra L; Herrero MJ; Puig C; Aliño SF
Pharmacogenomics; 2019 Jul; 20(10):741-763. PubMed ID: 31368847
[TBL] [Abstract][Full Text] [Related]
10. Implications of genetic testing in the management of colorectal cancer.
Stoehlmacher J; Lenz HJ
Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacogenomics on gastrointestinal cancer therapy.
Seufferlein T; Boehm BO
Pharmacogenomics; 2002 Sep; 3(5):625-33. PubMed ID: 12223048
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.
Bandrés E; Zárate R; Ramirez N; Abajo A; Bitarte N; Garíia-Foncillas J
World J Gastroenterol; 2007 Nov; 13(44):5888-901. PubMed ID: 17990354
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
16. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.
Panczyk M
World J Gastroenterol; 2014 Aug; 20(29):9775-827. PubMed ID: 25110414
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
[TBL] [Abstract][Full Text] [Related]
19. The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.
Schirripa M; Procaccio L; Lonardi S; Loupakis F
Pharmacogenomics; 2017 Feb; 18(3):197-200. PubMed ID: 28112993
[No Abstract] [Full Text] [Related]
20. Pharmacogenetic influences on treatment response and toxicity in colorectal cancer.
Tan BR; McLeod HL
Semin Oncol; 2005 Feb; 32(1):113-9. PubMed ID: 15726513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]